FILTER BY:
Details
A Study of Sacituzumab Govitecan in People with Mesothelioma
Address: 650 Commack Rd, Commack, NY 11725, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: True
- Peritoneal: False
- Pericardial: False
- Tunica Vaginalis: False
Type: Epitheliod, Sarcomatoid, Biphasic
Condition: Mesothelioma, Mesothelioma Pleural
Description: Participants will receive sacituzumab govitecan until their disease gets worse (progresses), they have severe side effects and cannot continue study treatment, or the participants or the study doctor thinks it's in your best interest to stop treatment.
Research Center: Memorial Sloan Kettering Commack
Treatment Interventions: DRUG: Sacituzumab govitecan-hziy
Potential Impact: Low
Clinical Trial Number: NCT06477419
Phase: Phase 2
Status: Recruiting
